Molecule Therapeutics Report Cover TrendFeedr

Molecule Therapeutics Report

: Analysis on the Market, Trends, and Technologies
341
TOTAL COMPANIES
Established
Topic Size
Strong
ANNUAL GROWTH
Plummeting
trending indicator
22.6B
TOTAL FUNDING
Maturing
Topic Maturity
Balanced
TREND HYPE
893.0
Monthly Search Volume
Published: September 18, 2024
Updated: September 16, 2024
Author: Maria Garcia

The molecule therapeutics business domain is a well-established field pivotal to healthcare, focusing on therapeutic molecules for medical purposes. With 341 companies actively operating and a maturing development stage, the sector has attracted significant investor interest, demonstrated by substantial funding ($22.6 billion) and revenue ($1.7 billion). Key trends include drug discovery, clinical trials, oncology, and bioavailability, with a focus on cutting-edge R&D. Despite stagnant growth in new company entries, annual funding and news coverage have seen impressive growth, indicating a ripe environment for innovation and advancement in molecule therapeutics.

We last updated this report 29 days ago. Tell us if you find something’s not quite right!

Topic Dominance Index of Molecule Therapeutics

The Dominance Index of Molecule Therapeutics looks at the evolution of the sector through a combination of multiple data sources. We analyze the distribution of news articles that mention Molecule Therapeutics, the timeline of newly founded companies working in this sector, and the share of voice within the global search data. All this combined gives a dominance index distribution of Molecule Therapeutics relative to all known Trends and Technologies.

Dominance Index growth in the last 5 years: -4.9%
Growth per month: -0.1%

Key Activities and Applications

  • Development of novel small molecules targeting fundamental biological pathways, especially in oncology.
  • Clinical-stage biopharmaceutical focus on areas such as cancer, viral infections, and inflammation.
  • Application of proprietary chemical entities to disrupt virus replication, block tumor growth, and enhance anti-tumor immune responses.
  • Bioanalysis services supporting pharmaceutical and biotech companies in the development of molecule therapeutics and biomarkers.
  • Targeting undruggable DNA Damage Response (DDR) Proteins for cancer therapeutics.
  • Focus on neurodegenerative diseases, targeting protein intermediates in disease pathways with small-molecule therapeutics.

Technologies and Methodologies

  • Utilization of proprietary platforms for small compound screening on disease models.
  • Advanced computational chemistry and data integration for designing oral medicines.
  • Deployment of generative AI and ultra-high throughput experimentation for drug discovery.
  • Novel electrospinning technology for sustained delivery of therapeutics.
  • Exploration of biodegradable polymers and defined pore sizes for drug elution profiles.

Molecule Therapeutics Funding

A total of 201 Molecule Therapeutics companies have received funding.
Overall, Molecule Therapeutics companies have raised $22.6B.
Companies within the Molecule Therapeutics domain have secured capital from 707 funding rounds.
The chart shows the funding trendline of Molecule Therapeutics companies over the last 5 years

Funding growth in the last 5 years: 332.51%
Growth per month: 2.6%

Molecule Therapeutics Companies

Uncover actionable market insights on 341 companies driving Molecule Therapeutics with TrendFeedr's Companies tool. The feature offers comprehensive data on innovative companies and technologies, essential for those looking to innovate and disrupt their industries.

companies image

341 Molecule Therapeutics Companies

Discover Molecule Therapeutics Companies, their Funding, Manpower, Revenues, Stages, and much more

View all Companies

Molecule Therapeutics Investors

Get ahead with your investment strategy with insights into 227 Molecule Therapeutics investors. TrendFeedr’s investors tool is your go-to source for comprehensive analysis of investment activities and financial trends. The tool is tailored for navigating the investment world, offering insights for successful market positioning and partnerships within Molecule Therapeutics.

investors image

227 Molecule Therapeutics Investors

Discover Molecule Therapeutics Investors, Funding Rounds, Invested Amounts, and Funding Growth

View all Investors

Molecule Therapeutics News

TrendFeedr’s News feature offers access to 1.1K news articles on Molecule Therapeutics. The tool provides up-to-date news on trends, technologies, and companies, enabling effective trend and sentiment tracking.

articles image

1.1K Molecule Therapeutics News Articles

Discover Latest Molecule Therapeutics Articles, News Magnitude, Publication Propagation, Yearly Growth, and Strongest Publications

View all Articles

Executive Summary

The molecule therapeutics sector is a dynamic and essential component of the healthcare and pharmaceutical industries, showing a strong trend towards innovation and development. Key activities include the advancement of small molecules for cancer treatment, viral infections, and inflammation, with a significant emphasis on oncology. The sector’s substantial growth in funding and media presence underscores its potential for further innovation. As the sector continues to mature, strategic investments and collaborations will be crucial in driving future advancements and addressing diseases with improved molecule therapeutics.

We value collaboration with industry professionals to offer even better insights. Interested in contributing? Get in touch!

StartUs Insights logo

Discover our Free Healthcare Trends Report

DOWNLOAD
Discover emerging Healthcare Trends!
We'll deliver our free report straight to your inbox!



    Protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Spot Emerging Trends Before Others

    Get access to the full database of 20,000 trends



      Protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.




        This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

        Let's talk!



          Protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.